The global race to develop new stem cell-based COVID-19 treatments during the pandemic was filled with violations of government regulations, inflated medical claims and distorted public communication, say the authors of a new perspective published Oct. 14 in the journalStem Cell Reports.
While stem cell therapy using stem cells to promote regeneration, repair or healing may be used to treat a limited number of diseases and conditions, there are currently no clinically tested or government-approved cell therapies available for the treatment or prevention of COVID-19 or its long-term effects.
However, this has not stopped the emergence of clinics offering unproven and unsafe stem cell therapies that promise to prevent COVID-19 by strengthening the immune system or improving overall health, says lead author Laertis Ikonomou, associate professor of oral biology, School of Dental Medicine.
The article explores the negative effects that misinformation about cell therapies has on public health, as well as the roles that researchers, science communicators and regulatory agencies should play in curbing the spread of inaccurate information and promoting responsible, accurate communication of research findings.
Efforts to rapidly develop therapeutic interventions should never occur at the expense of the ethical and scientific standards that are at the heart of responsible clinical research and innovation, says Ikonomou.
Scientists, regulators and policymakers must guard against the proliferation of poorly designed, underpowered and duplicative studies that are launched with undue haste because of the pandemic, but are unlikely to provide convincing, clinically meaningful safety and efficacy data, says co-author Leigh Turner, professor of health, society and behavior at the University of California, Irvine.
Other investigators include Megan Munsie, professor of ethics, education and policy in stem cell science at the University of Melbourne, and Aaron Levine, associate professor of public policy at Georgia Institute of Technology.
Many of the studies on possible stem cell-based COVID-19 treatments are at an early stage of investigation and further evaluation on larger sample sizes is required, says Munsie. However, the findings from preliminary studies are frequently exaggerated through press releases, social media and uncritical news media reports.
Given the urgency of the ongoing pandemic, even the smallest morsel of COVID-19 science is often deemed newsworthy and rapidly enters a social media landscape where regardless of its accuracy it can be widely shared with a global audience, says Levine.
Clinics selling supposed stem cell treatments on a direct-to-consumer basis sometimes use these findings and news reports to exploit the fears of vulnerable patients by unethically advertising the unproven benefits of stem cell treatments to boost the immune system, regenerate lung tissue and prevent transmission of COVID-19, says Turner.
There are reports of patients suffering physical harm including blindness and death from unproven stem cell therapies. Patients suffer financially as well, says Ikonomou, as the products range in price from a few thousand to tens of thousands of dollars, and people are often encouraged to receive the expensive treatments every few months.
Patients led to believe they are protected against COVID-19 may decide against vaccination, stop wearing masks, cease engaging in physical distancing, or otherwise avoid behaviors intended to promote personal safety and public health, says Turner. They may also become less likely to take part in carefully developed clinical trials conducted by companies that follow ethical standards.
The premature commercialization of cell-based therapeutics will inevitably harm the field of regenerative medicine, increase risks to patients and erode the publics trust, says Ikonomou.
The U.S. Food and Drug Administration and Federal Trade Commission have issued warnings to numerous offending clinics, yet many companies continue to make false claims.
The authors recommend that regulatory agencies consider implementing stronger measures to deter the sale of unlicensed products, such as issuing fines or criminal charges, revoking medical licenses or forcing clinics to return money to patients.
They also suggest that scientific and professional societies lobby regulatory agencies to increase enforcement of laws and regulations. Science communicators and journalists can combat misinformation by not engaging in hyperbolic coverage of research results and conveying study limitations, the authors say.
Read the original:
- University of Michigan Stem Cell Research | Frequently ... - November 30th, 2021
- Postdoctoral Research Associate in Centre for Stem Cells and Regenerative Medicine job with KINGS COLLEGE LONDON | 273388 - Times Higher Education... - November 30th, 2021
- Stem cell therapy potentially could treat Type 1 diabetes by helping patients produce insulin - USA TODAY - November 30th, 2021
- UCLA Broad Stem Cell Research Center receives $5 million ... - November 30th, 2021
- ReproCELL Incorporated : Everything you need to know about the REPROCELL iPSC Biobank - marketscreener.com - November 30th, 2021
- Cell therapy biotech Quell adds $156M for alternative to organ transplant meds - MedCity News - November 30th, 2021
- New nanochip reprograms cells in the body to perform different functions - New Atlas - November 30th, 2021
- Inside the Innovative Lab Growing Mammal Tissue Using Plants as Scaffolds - Smithsonian - November 30th, 2021
- BrainStorm Cell Therapeutics Announces the Presentation of New Analyses from the Phase 3 Trial of NurOwn in ALS at the 4th Annual ALS ONE Research... - November 30th, 2021
- 'Sleeping' cancer cells explain why childhood leukaemia returns after years of treatment - The Institute of Cancer Research, London - The Institute of... - November 30th, 2021
- 10 rare cancers: Symptoms, treatment, and more - Medical News Today - November 30th, 2021
- Heart repair and regeneration after a heart attack a review - The Mix - November 30th, 2021
- InGeneron Publishes Significant Support for the Existence of Naturally Pluripotent Stem Cells in All Organs in the Adult Body - StreetInsider.com - November 27th, 2021
- How the CGT Catapult plans to bridge the gap between scientific research and commercialisation - The Scotsman - November 27th, 2021
- Global $512M+ Exosome Diagnostics & Therapeutics Market, 2026 | Featuring Profiles of Codiak Biosciences, Evox Therapeutics, Exosome Diagnostics,... - November 27th, 2021
- Discovering a new gene in monkeys that could help to develop new antivirals - News-Medical.net - November 27th, 2021
- 2nd Person May Be Naturally 'Cured' of HIV: What Science Is Learning - Healthline - November 27th, 2021
- Research Roundup: Masking Cuts COVID-19 Risk in Half and More Research News - BioSpace - November 27th, 2021
- Stem Cell Research Facts - November 24th, 2021
- InGeneron Publishes Significant Support for the Existence of Naturally Pluripotent Stem Cells in All Organs in the Adult Body - marketscreener.com - November 24th, 2021
- Research Developments in the Treatment of Advanced Kidney Cancer - Warwick Beacon - November 24th, 2021
- Covid vaccine: Stem cell transplant patients who must be completely re-vaccinated struggling to book jabs - iNews - November 24th, 2021
- Amity University partners with top US varsities for academics and research - Telegraph India - November 24th, 2021
- AML relapse: Definition, statistics, and treatment options - Medical News Today - November 24th, 2021
- Its too late for me but please help others with cancer - Melton Times - November 22nd, 2021
- Research Developments in the Treatment of Advanced Kidney Cancer - The Apopka Voice - November 22nd, 2021
- How The Overlap Between Artificial Intelligence And Stem Cell Research Is Producing Exciting Results - Forbes - November 22nd, 2021
- California Proposition 14, Stem Cell Research Institute ... - November 22nd, 2021
- Theres Something Neurological Going On, COVID Could Cause Depression And Anxiety, Researchers Say - CBS Baltimore - November 22nd, 2021
- Exosome Diagnostics and Therapeutics: Global Markets - Yahoo Finance - November 22nd, 2021
- Flying cars and floating cities these 8 radical designs predict our imminent future - Boston News, Weather, Sports | WHDH 7News - November 22nd, 2021
- Researchers discover new type of cell that may help regulate heart rate - News-Medical.net - November 22nd, 2021
- The Promise of Stem Cells to Help Children with Autism - Entrepreneur - November 21st, 2021
- Stem cell transplants without chemo and radiation first? - Futurity: Research News - November 16th, 2021
- Unregulated Stem Cell Clinics Endanger Patients And Limit Research - Forbes - November 16th, 2021
- Regenerative Medicine Market Size Worth $ ~41.45 billion by 2031 - Market Size, Share, Forecasts and Trends Analysis Report with COVID-19 Impact by... - November 16th, 2021
- Stem Cell Therapy Reduces Need for Nearly 10% of Hip Replacements - Yale School of Medicine - November 16th, 2021
- Overlooked DNA may be what separates humans from other primates study - The Jerusalem Post - November 16th, 2021
- In-depth Research on Cancer Stem Cell Market Forecast Estimation & Approach 2021-2026 | Thermo Fisher Scientific, AbbVie, Merck KGaA, Bionomics,... - November 16th, 2021
- NK Cell Therapy and Stem Cell Therapy Market Cumulative Impact for COVID-19 Recovery Research Report 2021 | Takeda Pharmaceutical, JCR Pharmaceutical,... - November 16th, 2021
- Stem Cell Therapy Market Analysis By Trends, Size, Share, Company Overview, Growth And Forecast By 2027|Osiris Therapeutics, NuVasive, Chiesi... - November 16th, 2021
- Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT - Yahoo Finance - November 16th, 2021
- Research Antibodies Market Size Is Projected to Reach $6.35 Billion by 2028 | CAGR: 6.5% : Polaris Market Research - PRNewswire - November 16th, 2021
- Jasper Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update - Tyler Morning Telegraph - November 16th, 2021
- $2.26 million in grants will support biomedic - EurekAlert - November 16th, 2021
- What science knows about stem cells and what it predicts in the future | CoFounder - CoFounder Magazine - November 11th, 2021
- Jasper Therapeutics Announces Research Collaboration with AVROBIO to Evaluate JSP191 as Conditioning Agent in Clinical Studies of Ex Vivo Lentiviral... - November 11th, 2021
- Stem Cell Characterization and Analysis Tool Market 2021 Detailed Analysis of top Ventures with Regional Outlook | Key Companies: Osiris Therapeutics,... - November 11th, 2021
- Global Stem Cell Umbilical Cord Blood (UCB) Market Insightful Research Report: Business Growth, Development Factors, Current and Future Trends and... - November 11th, 2021
- Century Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates - The Bakersfield Californian - November 11th, 2021
- 2021 Boston Investment Conference Marks Decade of Helping Fund Critical Research at Boston Childrens Hospital - Yahoo Finance - November 11th, 2021
- Yale researchers develop RNA-based therapy that clears SARS-CoV-2 from mice - EurekAlert - November 11th, 2021
- Critical Link Discovered Between Dietary Fat and the Spread of Cancer - SciTechDaily - November 11th, 2021
- Opinion | How Covid Raised the Stakes of the War Between Faith and Science - The New York Times - November 11th, 2021
- EdiGene to Present Latest Research on A Novel Surface Marker and Migration of Hematopoietic Stem Cell (HSC) That Could Enhance HSC Gene Therapy and... - November 5th, 2021
- Century Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Host Virtual Research & Development Update - Yahoo... - November 5th, 2021
- City of Hope Doctors Present New Research on Cancer Immunotherapies - Business Wire - November 5th, 2021
- Mini-brain model of frontotemporal dementia demonstrates the stages of dysfunction that lead to cell death - National Institute on Aging - November 5th, 2021
- Intestinal Organoids and Their Role in Tissue Engineering - Technology Networks - November 5th, 2021
- Magenta Therapeutics Reports Third Quarter Financial Results and Program Highlights - Business Wire - November 5th, 2021
- Researchers generate and characterize the hepatic organoid culture system - News-Medical.net - November 3rd, 2021
- A major research project to advance regenerative therapy for epidermolysis bullosa (EB) using transgenic stem cells - PR Web - November 3rd, 2021
- Canada Biobanks Markets, Analysis & Forecasts, 2016-2020 & 2021-2026 - Increased Research and Technological Advancement in Genomic Studies -... - November 3rd, 2021
- Study paves the way for a better understanding of muscle injury - News-Medical.Net - November 3rd, 2021
- Lab-Growing Everything Might Be The Only Way To Attain A Sustainable World - Intelligent Living - November 3rd, 2021
- What is Stem Cell Research? | The Benefits of Stem Cell ... - October 26th, 2021
- New Treatments and Tips for Dealing With Blood Cancer - Curetoday.com - October 26th, 2021
- NK Cell Therapy and Stem Cell Therapy Market Cumulative Impact for COVID-19 Recovery Research Report 2021 | Chiesi Pharmaceuticals, Takeda... - October 25th, 2021
- Skroot Laboratory, Inc. Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery - KOLO - October 23rd, 2021
- New GBM research pipeline and being glad - Brain Tumour Research - October 23rd, 2021
- Excellent Growth of Cell Separation Technology Market by Trends, Dynamic Innovation and Key Players GE, BD, Terumo, Merck, Thermo Fisher | Forecast... - October 23rd, 2021
- What Makes Us Human? The Answer May Be Found in Overlooked Junk DNA - SciTechDaily - October 21st, 2021
- Stem Cell Therapy Market SWOT Analysis, Key Indicators, Forecast 2027 | Anterogen Co., Ltd. (South Korea), MEDIPOST Co., Ltd. (South Korea), Osiris... - October 21st, 2021
- Stem Cell Therapy Market: Shaping Tomorrow with Anterogen Co., Ltd. (South Korea), MEDIPOST Co., Ltd. (South Korea), Osiris Therapeutics Puck77 -... - October 21st, 2021
- Liu receives Catalyst Award from the National Institutes of Health agency - Harvard School of Engineering and Applied Sciences - October 21st, 2021
- Stem Cell Therapy Market 2021 Financial Highlights Analysis with Top Key Players: Anterogen Co., Ltd. (South Korea), MEDIPOST Co., Ltd. (South Korea),... - October 21st, 2021
- Stem Cell Therapy Market 2025 Size, Key Companies, Trends, Growth And Regional Forecasts Research | Anterogen Co., Ltd. (South Korea), MEDIPOST Co.,... - October 21st, 2021
- Scientists use human-derived brain cells to develop more realistic 'disease-in-a-dish' models of Alzheimer's - National Institute on Aging - October 21st, 2021
- Harvard's R&D alliance with Resilience to advance manufacture of complex medicines - Harvard Gazette - October 17th, 2021
- Research Roundup: T-Cell Immune Response to COVID-19 Vaccines and More - BioSpace - October 17th, 2021